KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma. (Q39485955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

title

KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

Tanwir Habib

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

Puthen Jithesh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

Laura Moro

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Arcangela G Manente

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

Sara Zonca

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

Daniela Tavian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

Dean Fennell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

Stefan Nilsson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

publication date

16 August 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

1227-1238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden

21 March 2020

cites work

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Investigational Approaches for Mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Prognostic factors in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Estrogen receptor-beta affects the prognosis of human malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Profile of histone lysine methylation across transcribed mammalian chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Epigenetic regulation by histone demethylases in hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

JMJD3 as an epigenetic regulator in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

18S is an appropriate housekeeping gene for in vitro hypoxia experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2α.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

HIF-1: upstream and downstream of cancer metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

HIF-1 signaling in drug resistance to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Hypoxia affects in vitro growth of newly established cell lines from patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Prolyl 4-hydroxylases, master regulators of the hypoxia response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

The epigenomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Loss of BAP1 function leads to EZH2-dependent transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

HIF-1-dependent induction of Jumonji domain-containing protein (JMJD) 3 under hypoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Passing the baton: the HIF switch

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/EPI-2016-0025

21 January 2018

Identifiers

DOI

10.2217/EPI-2016-0025

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27529370 AND SRC:MED&resulttype=core&format=json

21 March 2020

1 reference